NewGenIvf Group Limited
NIVF
$1.78
$0.031.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 5.79% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 5.79% | -- | -- | -- | |
| Cost of Revenue | 4.40% | -- | -- | -- | |
| Gross Profit | 8.63% | -- | -- | -- | |
| SG&A Expenses | 82.20% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 29.44% | -- | -- | -- | |
| Operating Income | -2,836.79% | -- | -- | -- | |
| Income Before Tax | -985.53% | -- | -- | -- | |
| Income Tax Expenses | -486,800.00% | -- | -- | -- | |
| Earnings from Continuing Operations | -537.36% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -333.18% | -- | -- | -- | |
| Net Income | -502.69% | -- | -- | -- | |
| EBIT | -2,836.79% | -- | -- | -- | |
| EBITDA | -1,381.91% | -- | -- | -- | |
| EPS Basic | -404.03% | -- | -- | -- | |
| Normalized Basic EPS | -731.53% | -- | -- | -- | |
| EPS Diluted | -404.72% | -- | -- | -- | |
| Normalized Diluted EPS | -731.53% | -- | -- | -- | |
| Average Basic Shares Outstanding | 160.09% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 160.09% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |